Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01627535 |
Recruitment Status
:
Completed
First Posted
: June 25, 2012
Last Update Posted
: January 20, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Brain Tumor | Other: Interoperative Optical Imaging and Spectroscopy | Not Applicable |
PRIMARY OBJECTIVES:
I. To develop the instrumentation to achieve real time processing and display of intraoperative 2-dimensional optical imaging and spectroscopy (i2DOS) maps in the operating arena.
II. To examine the timing and spatial involvement of human cortex intraoperatively to different stimuli using i2DOS.
OUTLINE: Patients undergo i2DOS.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 4 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors |
Study Start Date : | May 2013 |
Actual Primary Completion Date : | January 2016 |
Actual Study Completion Date : | January 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Optical Imaging
Patients undergo i2DOS
|
Other: Interoperative Optical Imaging and Spectroscopy
Real time processing and display of i2DOS maps in the operating arena
|
- Determination of the effectiveness of intraoperative optical imaging technology and optical spectroscopy. [ Time Frame: Day 1 post surgery ]Optical reflectance images will be analyzed by pixel by-pixel subtraction of a control trial and a stimulation trial. This subtracted image will then be divided by the control image to normalize for differences between subjects and trials. These ratios thus represent proportional changes from baseline.
- Intraoperative determination of the location of critical brain functions. [ Time Frame: Day 1 post surgery ]We will examine the timing and spatial involvement of human cortex intraoperatively to different stimuli using i2DOS. Stimulus parameters will be varied to investigate stimulus-response relationships. We will study areas of sensori-motor and language cortex using customary stimuli for evoked potentials (i.e. transcutaneous electrical nerve stimulation), tactile stimuli for exposed cortical dermatome representations, and language tasks for cortical language representations. Results will be correlated with intraoperative electrophysiological measures.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Neurosurgical patient population in the City of Hope brain and spinal tumor neurosurgical programs that have been diagnosed with a brain tumor.
- Only lucid patients qualified to consent to neurosurgical procedure will be approached for participation in this study.
- We do intend to enroll subjects with potentially terminal brain tumors. Due to the potential benefit of intraoperative mapping, we are not planning to exclude these subjects.
- Patients with any type of brain tumor will be eligible for participation.
- All subjects must have the ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
- There are no exclusion criteria except for individuals without a brain tumor and the location of the craniotomy. If the exposed area of brain is not compatible with peripheral stimuli or volitional activity the subject cannot be enrolled.
- Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01627535
United States, California | |
City of Hope Medical Center | |
Duarte, California, United States, 91010 |
Principal Investigator: | Neal Prakash, MD, PhD | City of Hope Medical Center |
Responsible Party: | City of Hope Medical Center |
ClinicalTrials.gov Identifier: | NCT01627535 History of Changes |
Other Study ID Numbers: |
11320 NCI-2012-01074 ( Registry Identifier: NCI CTRP ) |
First Posted: | June 25, 2012 Key Record Dates |
Last Update Posted: | January 20, 2016 |
Last Verified: | January 2016 |
Keywords provided by City of Hope Medical Center:
Brain Tumor |
Additional relevant MeSH terms:
Brain Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site |
Neoplasms Brain Diseases Central Nervous System Diseases Nervous System Diseases |